Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      ACTIVE_NOT_RECRUITING
      A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours
      Description

      This is a first-in-human Phase 1 clinical trial designed to investigate the safety, tolerability, pharmacokinetics, and biodistribution of \[225Ac\]-FPI-2059 and \[111In\]-FPI-2058 in participants with neurotensin receptor 1 (NTSR1)-expressing solid tumours.

      Conditions
      Pancreatic Ductal Adenocarcinoma (PDAC)Squamous Cell Carcinoma of Head and NeckColorectal CancerGastric CancerEwing SarcomaNTSR1 Expressing Solid TumoursNeuroendocrine Differentiated (NED) Prostate Cancer
      Talk to us